This comprehensive report provides a detailed analysis of the global fish skin disease market, projecting steady growth through 2032. The study examines key market drivers and trends across various segments, including antibiotics, vaccines, and probiotics, catering to aquaculture producers and fisheries. By evaluating regional dynamics and the competitive landscape of leading players like Zoetis and Elanco, the report identifies emerging opportunities and strategic shifts within the industry to guide informed decision-making.

Market Overview

Global Market Projections

The global Fish Skin Disease market size is predicted to grow from US$ 2040 million in 2025 to US$ 3324 million in 2032, representing a compound annual growth rate (CAGR) of 7.4% from 2026 to 2032.

Regional Market Projections

• United States: The market for Fish Skin Disease is estimated to experience growth from 2025 through 2032 at a steady compound annual growth rate.
• China: The market for Fish Skin Disease is estimated to experience growth from 2025 through 2032 at a steady compound annual growth rate.
• Europe: The market for Fish Skin Disease is estimated to experience growth from 2025 through 2032 at a steady compound annual growth rate.

Report Scope and Methodology

Research Objectives

LPI (LP Information)' newest research report, the “Fish Skin Disease Industry Forecast,” reviews total world Fish Skin Disease sales in 2025 based on past sales data. The report provides a comprehensive analysis of projected Fish Skin Disease sales for 2026 through 2032, broken down by region, market sector, and sub-sector, presented in US$ millions.

This Insight Report provides a comprehensive analysis of the global Fish Skin Disease landscape and highlights key trends related to:

• Product segmentation
• Company formation
• Revenue and market share
• Latest developments
• M&A activity

Furthermore, the report analyzes the strategies of leading global companies, focusing on their Fish Skin Disease portfolios and capabilities, market entry strategies, market positions, and geographic footprints to better understand their unique positions in an accelerating global market.

Analytical Approach

The report evaluates key market trends, drivers, and affecting factors shaping the global outlook for Fish Skin Disease. It breaks down the forecast by Type, Application, geography, and market size to highlight emerging pockets of opportunity. Utilizing a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study offers a highly nuanced view of the current state and future trajectory of the global Fish Skin Disease industry.

This report presents a comprehensive overview, market shares, and growth opportunities of the Fish Skin Disease market by product type, application, key players, and key regions and countries.

Market Segmentation

By Type

• Antibiotics
• Vaccines
• Probiotics
• Phage Therapy
• Other Natural Treatments

By Application

• Aquaculture Producers
• Fisheries
• Other organizations

By Geography

• Americas: United States, Canada, Mexico, Brazil
• APAC: China, Japan, Korea, Southeast Asia, India, Australia
• Europe: Germany, France, UK, Italy, Russia
• Middle East & Africa: Egypt, South Africa, Israel, Turkey, GCC Countries

Competitive Landscape

Market Dynamics

Global key Fish Skin Disease players include Zoetis Inc., Elanco Animal Health, Norvartis, MSD Animal Health, and Benchmark Holdings. In terms of revenue, the global two largest companies occupied a significant share of the market in 2025.

Key Profiled Companies

The following companies have been profiled based on inputs gathered from primary experts and analysis of their coverage, product portfolio, and market penetration:

• Zoetis Inc.
• Elanco Animal Health
• Norvartis
• MSD Animal Health
• Benchmark Holdings
• Phibro Animal Health Corporation
• Intervet Inc.
• Merck Animal Health
• Novartis AG
• Pharmaq AS
• AquaBounty Technologies
• Alltech
• Nutreco
• Biomin
• Skretting

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Fish Skin Disease Market Size (2021-2032)

    • 2.1.2 Fish Skin Disease Market Size CAGR by Region (2021 VS 2025 VS 2032)

    • 2.1.3 World Current & Future Analysis for Fish Skin Disease by Country/Region (2021, 2025 & 2032)

  • 2.2 Fish Skin Disease Segment by Type

    • 2.2.1 Antibiotics

    • 2.2.2 Vaccines

    • 2.2.3 Probiotics

    • 2.2.4 Phage Therapy

    • 2.2.5 Other Natural Treatments

    • 2.2.6 Fish Skin Disease Market Size by Type

      • 2.2.6.1 Fish Skin Disease Market Size CAGR by Type (2021 VS 2025 VS 2032)
      • 2.2.6.2 Global Fish Skin Disease Market Size Market Share by Type (2021-2026)

  • 2.3 Fish Skin Disease Segment by Application

    • 2.3.1 Aquaculture Producers

    • 2.3.2 Fisheries

    • 2.3.3 Other organizations

    • 2.3.4 Fish Skin Disease Market Size by Application

      • 2.3.4.1 Fish Skin Disease Market Size CAGR by Application (2021 VS 2025 VS 2032)
      • 2.3.4.2 Global Fish Skin Disease Market Size Market Share by Application (2021-2026)

• 3 Fish Skin Disease Market Size by Player

  • 3.1 Fish Skin Disease Market Size Market Share by Player

    • 3.1.1 Global Fish Skin Disease Revenue by Player (2021-2026)

    • 3.1.2 Global Fish Skin Disease Revenue Market Share by Player (2021-2026)

  • 3.2 Global Fish Skin Disease Key Players Head office and Products Offered

  • 3.3 Market Concentration Rate Analysis

    • 3.3.1 Competition Landscape Analysis

    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.4 New Products and Potential Entrants

  • 3.5 Mergers & Acquisitions, Expansion

• 4 Fish Skin Disease by Region

  • 4.1 Fish Skin Disease Market Size by Region (2021-2026)

  • 4.2 Global Fish Skin Disease Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Fish Skin Disease Market Size Growth (2021-2026)

  • 4.4 APAC Fish Skin Disease Market Size Growth (2021-2026)

  • 4.5 Europe Fish Skin Disease Market Size Growth (2021-2026)

  • 4.6 Middle East & Africa Fish Skin Disease Market Size Growth (2021-2026)

• 5 Americas

  • 5.1 Americas Fish Skin Disease Market Size by Country (2021-2026)

  • 5.2 Americas Fish Skin Disease Market Size by Type (2021-2026)

  • 5.3 Americas Fish Skin Disease Market Size by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Fish Skin Disease Market Size by Region (2021-2026)

  • 6.2 APAC Fish Skin Disease Market Size by Type (2021-2026)

  • 6.3 APAC Fish Skin Disease Market Size by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

• 7 Europe

  • 7.1 Europe Fish Skin Disease Market Size by Country (2021-2026)

  • 7.2 Europe Fish Skin Disease Market Size by Type (2021-2026)

  • 7.3 Europe Fish Skin Disease Market Size by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Fish Skin Disease by Region (2021-2026)

  • 8.2 Middle East & Africa Fish Skin Disease Market Size by Type (2021-2026)

  • 8.3 Middle East & Africa Fish Skin Disease Market Size by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Global Fish Skin Disease Market Forecast

  • 10.1 Global Fish Skin Disease Forecast by Region (2027-2032)

    • 10.1.1 Global Fish Skin Disease Forecast by Region (2027-2032)

    • 10.1.2 Americas Fish Skin Disease Forecast

    • 10.1.3 APAC Fish Skin Disease Forecast

    • 10.1.4 Europe Fish Skin Disease Forecast

    • 10.1.5 Middle East & Africa Fish Skin Disease Forecast

  • 10.2 Americas Fish Skin Disease Forecast by Country (2027-2032)

    • 10.2.1 United States Market Fish Skin Disease Forecast

    • 10.2.2 Canada Market Fish Skin Disease Forecast

    • 10.2.3 Mexico Market Fish Skin Disease Forecast

    • 10.2.4 Brazil Market Fish Skin Disease Forecast

  • 10.3 APAC Fish Skin Disease Forecast by Region (2027-2032)

    • 10.3.1 China Fish Skin Disease Market Forecast

    • 10.3.2 Japan Market Fish Skin Disease Forecast

    • 10.3.3 Korea Market Fish Skin Disease Forecast

    • 10.3.4 Southeast Asia Market Fish Skin Disease Forecast

    • 10.3.5 India Market Fish Skin Disease Forecast

    • 10.3.6 Australia Market Fish Skin Disease Forecast

  • 10.4 Europe Fish Skin Disease Forecast by Country (2027-2032)

    • 10.4.1 Germany Market Fish Skin Disease Forecast

    • 10.4.2 France Market Fish Skin Disease Forecast

    • 10.4.3 UK Market Fish Skin Disease Forecast

    • 10.4.4 Italy Market Fish Skin Disease Forecast

    • 10.4.5 Russia Market Fish Skin Disease Forecast

  • 10.5 Middle East & Africa Fish Skin Disease Forecast by Region (2027-2032)

    • 10.5.1 Egypt Market Fish Skin Disease Forecast

    • 10.5.2 South Africa Market Fish Skin Disease Forecast

    • 10.5.3 Israel Market Fish Skin Disease Forecast

    • 10.5.4 Turkey Market Fish Skin Disease Forecast

  • 10.6 Global Fish Skin Disease Forecast by Type (2027-2032)

  • 10.7 Global Fish Skin Disease Forecast by Application (2027-2032)

    • 10.7.1 GCC Countries Market Fish Skin Disease Forecast

• 11 Key Players Analysis

  • 11.1 Zoetis Inc.

    • 11.1.1 Zoetis Inc. Company Information

    • 11.1.2 Zoetis Inc. Fish Skin Disease Product Offered

    • 11.1.3 Zoetis Inc. Fish Skin Disease Revenue, Gross Margin and Market Share (2021-2026)

    • 11.1.4 Zoetis Inc. Main Business Overview

    • 11.1.5 Zoetis Inc. Latest Developments

  • 11.2 Elanco Animal Health

    • 11.2.1 Elanco Animal Health Company Information

    • 11.2.2 Elanco Animal Health Fish Skin Disease Product Offered

    • 11.2.3 Elanco Animal Health Fish Skin Disease Revenue, Gross Margin and Market Share (2021-2026)

    • 11.2.4 Elanco Animal Health Main Business Overview

    • 11.2.5 Elanco Animal Health Latest Developments

  • 11.3 Norvartis

    • 11.3.1 Norvartis Company Information

    • 11.3.2 Norvartis Fish Skin Disease Product Offered

    • 11.3.3 Norvartis Fish Skin Disease Revenue, Gross Margin and Market Share (2021-2026)

    • 11.3.4 Norvartis Main Business Overview

    • 11.3.5 Norvartis Latest Developments

  • 11.4 MSD Animal Health

    • 11.4.1 MSD Animal Health Company Information

    • 11.4.2 MSD Animal Health Fish Skin Disease Product Offered

    • 11.4.3 MSD Animal Health Fish Skin Disease Revenue, Gross Margin and Market Share (2021-2026)

    • 11.4.4 MSD Animal Health Main Business Overview

    • 11.4.5 MSD Animal Health Latest Developments

  • 11.5 Benchmark Holdings

    • 11.5.1 Benchmark Holdings Company Information

    • 11.5.2 Benchmark Holdings Fish Skin Disease Product Offered

    • 11.5.3 Benchmark Holdings Fish Skin Disease Revenue, Gross Margin and Market Share (2021-2026)

    • 11.5.4 Benchmark Holdings Main Business Overview

    • 11.5.5 Benchmark Holdings Latest Developments

  • 11.6 Phibro Animal Health Corporation

    • 11.6.1 Phibro Animal Health Corporation Company Information

    • 11.6.2 Phibro Animal Health Corporation Fish Skin Disease Product Offered

    • 11.6.3 Phibro Animal Health Corporation Fish Skin Disease Revenue, Gross Margin and Market Share (2021-2026)

    • 11.6.4 Phibro Animal Health Corporation Main Business Overview

    • 11.6.5 Phibro Animal Health Corporation Latest Developments

  • 11.7 Intervet Inc.

    • 11.7.1 Intervet Inc. Company Information

    • 11.7.2 Intervet Inc. Fish Skin Disease Product Offered

    • 11.7.3 Intervet Inc. Fish Skin Disease Revenue, Gross Margin and Market Share (2021-2026)

    • 11.7.4 Intervet Inc. Main Business Overview

    • 11.7.5 Intervet Inc. Latest Developments

  • 11.8 Merck Animal Health

    • 11.8.1 Merck Animal Health Company Information

    • 11.8.2 Merck Animal Health Fish Skin Disease Product Offered

    • 11.8.3 Merck Animal Health Fish Skin Disease Revenue, Gross Margin and Market Share (2021-2026)

    • 11.8.4 Merck Animal Health Main Business Overview

    • 11.8.5 Merck Animal Health Latest Developments

  • 11.9 Novartis AG

    • 11.9.1 Novartis AG Company Information

    • 11.9.2 Novartis AG Fish Skin Disease Product Offered

    • 11.9.3 Novartis AG Fish Skin Disease Revenue, Gross Margin and Market Share (2021-2026)

    • 11.9.4 Novartis AG Main Business Overview

    • 11.9.5 Novartis AG Latest Developments

  • 11.10 Pharmaq AS

    • 11.10.1 Pharmaq AS Company Information

    • 11.10.2 Pharmaq AS Fish Skin Disease Product Offered

    • 11.10.3 Pharmaq AS Fish Skin Disease Revenue, Gross Margin and Market Share (2021-2026)

    • 11.10.4 Pharmaq AS Main Business Overview

    • 11.10.5 Pharmaq AS Latest Developments

  • 11.11 AquaBounty Technologies

    • 11.11.1 AquaBounty Technologies Company Information

    • 11.11.2 AquaBounty Technologies Fish Skin Disease Product Offered

    • 11.11.3 AquaBounty Technologies Fish Skin Disease Revenue, Gross Margin and Market Share (2021-2026)

    • 11.11.4 AquaBounty Technologies Main Business Overview

    • 11.11.5 AquaBounty Technologies Latest Developments

  • 11.12 Alltech

    • 11.12.1 Alltech Company Information

    • 11.12.2 Alltech Fish Skin Disease Product Offered

    • 11.12.3 Alltech Fish Skin Disease Revenue, Gross Margin and Market Share (2021-2026)

    • 11.12.4 Alltech Main Business Overview

    • 11.12.5 Alltech Latest Developments

  • 11.13 Nutreco

    • 11.13.1 Nutreco Company Information

    • 11.13.2 Nutreco Fish Skin Disease Product Offered

    • 11.13.3 Nutreco Fish Skin Disease Revenue, Gross Margin and Market Share (2021-2026)

    • 11.13.4 Nutreco Main Business Overview

    • 11.13.5 Nutreco Latest Developments

  • 11.14 Biomin

    • 11.14.1 Biomin Company Information

    • 11.14.2 Biomin Fish Skin Disease Product Offered

    • 11.14.3 Biomin Fish Skin Disease Revenue, Gross Margin and Market Share (2021-2026)

    • 11.14.4 Biomin Main Business Overview

    • 11.14.5 Biomin Latest Developments

  • 11.15 Skretting

    • 11.15.1 Skretting Company Information

    • 11.15.2 Skretting Fish Skin Disease Product Offered

    • 11.15.3 Skretting Fish Skin Disease Revenue, Gross Margin and Market Share (2021-2026)

    • 11.15.4 Skretting Main Business Overview

    • 11.15.5 Skretting Latest Developments

• 12 Research Findings and Conclusion